Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tuberculosis in HIV programmes in lower-income countries: practices and risk factors.
Fenner L, Forster M, Boulle A, Phiri S, Braitstein P, Lewden C, Schechter M, Kumarasamy N, Pascoe M, Sprinz E, Bangsberg DR, Sow PS, Dickinson D, Fox MP, McIntyre J, Khongphatthanayothin M, Dabis F, Brinkhof MW, Wood R, Egger M; ART-LINC of IeDEA. Fenner L, et al. Among authors: sprinz e. Int J Tuberc Lung Dis. 2011 May;15(5):620-7. doi: 10.5588/ijtld.10.0249. Int J Tuberc Lung Dis. 2011. PMID: 21756512 Free PMC article.
Prioritising prevention strategies for patients in antiretroviral treatment programmes in resource-limited settings.
Spaar A, Graber C, Dabis F, Coutsoudis A, Bachmann L, McIntyre J, Schechter M, Prozesky HW, Tuboi S, Dickinson D, Kumarasamy N, Pujdades-Rodriquez M, Sprinz E, Schilthuis HJ, Cahn P, Low N, Egger M; ART-LINC of IeDEA. Spaar A, et al. Among authors: sprinz e. AIDS Care. 2010 Jun;22(6):775-83. doi: 10.1080/09540120903349102. AIDS Care. 2010. PMID: 20473792 Free PMC article.
Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration.
Braitstein P, Boulle A, Nash D, Brinkhof MW, Dabis F, Laurent C, Schechter M, Tuboi SH, Sprinz E, Miotti P, Hosseinipour M, May M, Egger M, Bangsberg DR, Low N; Antiretroviral Therapy in Lower Income Countries (ART-LINC) study group. Braitstein P, et al. Among authors: sprinz e. J Womens Health (Larchmt). 2008 Jan-Feb;17(1):47-55. doi: 10.1089/jwh.2007.0353. J Womens Health (Larchmt). 2008. PMID: 18240981
Dengue and primary care: a tale of two cities.
Roriz-Cruz M, Sprinz E, Rosset I, Goldani L, Teixeira MG. Roriz-Cruz M, et al. Among authors: sprinz e. Bull World Health Organ. 2010 Apr;88(4):244-5. doi: 10.2471/BLT.10.076935. Bull World Health Organ. 2010. PMID: 20431782 Free PMC article. No abstract available.
A national cross-sectional analysis of surveillance drug resistance mutations among recently diagnosed antiretroviral naïve Brazilian people with HIV.
Caldeira DB, Constant Vergara TR, Schechter M, Bicudo EL, Freitas Lopes CA, Brites C, Sprinz E, Fernandes JC, Silveira OS, Durães-Carvalho R, Galinskas J, Treitsman MS, Gomes de Sousa MD, de Figueiredo Fernandes M, Helfer MS, Grilo NA, Caseiro MM, Sanz Duro RL, Bassini AS, Hunter JR, Janini LM, Diaz RS. Caldeira DB, et al. Among authors: sprinz e. Lancet Reg Health Am. 2025 Oct 31;52:101283. doi: 10.1016/j.lana.2025.101283. eCollection 2025 Dec. Lancet Reg Health Am. 2025. PMID: 41255959 Free PMC article.
Clinical outcomes of dolutegravir treatment in people living with HIV in Brazil: protocol for the CODE cohort.
Brites C, Luz E, Stelitano C, Bahia F, de Lacerda MVG, Ramalho A, Cardoso SW, Madruga V, Reuter T, Barbosa AN, Sperhack RD, Bay MB, Newman T, Morejon K, Patelli M, Leal F, Sprinz E, Murray-Krezan C, Carmody M, Anderson J, Aragon A, Chase B, Zajdenverg R, Jones B, Dutra F, Page K. Brites C, et al. Among authors: sprinz e. BMC Infect Dis. 2025 Oct 8;25(1):1248. doi: 10.1186/s12879-025-11700-0. BMC Infect Dis. 2025. PMID: 41062955 Free PMC article.
Efficacy and Safety of Dual Therapy With Dolutegravir/Lamivudine in Treatment-naive Persons With CD4 Counts <200/mm3: 48-Week Results of the DOLCE Study.
Figueroa MI, Brites C, Cecchini D, Ramalho A, Francos JL, Lacerda M, Rolon MJ, Madruga JV, Sprinz E, Souza TNL, Parenti P, Converso D, Mernies G, Sued O, Cahn P; DOLCE study group. Figueroa MI, et al. Among authors: sprinz e. Clin Infect Dis. 2025 Aug 28:ciaf415. doi: 10.1093/cid/ciaf415. Online ahead of print. Clin Infect Dis. 2025. PMID: 40874763
Immunogenicity and Safety of ChAdOx1 nCoV-19 (AZD1222) as a Homologous Fourth-Dose Booster: A Substudy of the Phase 3 COV003 Trial in Brazil.
Costa Clemens SA, Bibi S, Marchevsky NG, Aley PK, Cappuccini F, Davies SA, Gonzalez I, Kelly SC, Mujadidi YF, Pipolo Milan E, Schwarzbold AV, Sprinz E, Voysey M, Weckx LY, Wright D, Bansal H, Bergagård MAS, Isaacs AJ, Kelly EJ, Lan D, Morgan S, Shankar NK, Shoemaker K, Villafana TL, Lambe T, Green JA, Pollard AJ. Costa Clemens SA, et al. Among authors: sprinz e. Mayo Clin Proc Innov Qual Outcomes. 2025 Jul 11;9(4):100642. doi: 10.1016/j.mayocpiqo.2025.100642. eCollection 2025 Aug. Mayo Clin Proc Innov Qual Outcomes. 2025. PMID: 40686533 Free PMC article.
Performance of urine Xpert MTB/RIF ultra in a tuberculosis screening strategy in hospitalized patients with advanced HIV disease: Results from an implementation initiative in Brazil.
Falci DR, Pasqualotto AC, Vieceli T, Sued O, Reis N, Soares RBA, Godoy CSM, Hatem NA, Dos Santos NP, Regis Razzolini B, Sprinz E, Perez F. Falci DR, et al. Among authors: sprinz e. HIV Med. 2025 Mar;26(3):427-433. doi: 10.1111/hiv.13746. Epub 2024 Dec 10. HIV Med. 2025. PMID: 39657975
116 results